'I had a bit of a reaction': GMB's Susanna Reid opens up about her Covid vaccine response

The UK government has launched a string of measures aimed at neutralising the threat of the new Omicron variant. The booster programme has been beefed up, with all adults over 18 now eligible to receive a booster vaccine. Although the UK has relatively high uptake rates, hesitancy persists. This is owing to fears about the possible side effects.

I had a little of bit of a reaction,” she revealed.

Susanna continued: “I didn’t feel 100 percent for 24 hours. That’s something that I have taken into account.”

Booster vaccines – safety and possible side effects

The risks posed by the booster shots are minimal and side effects are mainly mild, a new UK study suggests.

The peer-reviewed phase 2 trial, published Thursday in The Lancet medical journal, looked at the safety and efficacy of seven vaccines given after two initial doses of either the Oxford-AstraZeneca or Pfizer-BioNTech vaccine.

Vaccines included in the study were those produced by Oxford-AstraZeneca, Pfizer-BioNTech, Novavax, Johnson & Johnson, Moderna, Valneva and Curevac.

The study, which involved 2,878 adults over the age of 30, found that none of the seven vaccines posed safety concerns.

Fatigue, headaches, and pain at the injection site were the most common side effects, and were mostly reported in younger people.

A total of 912 participants experienced adverse events from their booster shot, with 24 severe events being reported during the study.


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.